Loading...
Current U.S. guidelines recommend surveillance for patients with adenomas at intervals determined by polyp size, number, and histology. However, surveillance requires significant colonoscopy resources, and there are limited long-term data to support current recommendations.
In a modeling study, researchers predicted the lifetime benefits, costs, and cost-effectiveness of different surveillance strategies. The simulated population included average-risk patients aged 50, 60, and 70 years with low-risk adenomas (LRAs; 1–2 adenomas <10 mm) or high-risk adenomas (HRAs; 3–10 small adenomas or at least one adenoma ≥10 mm) at baseline colonoscopy. The model assessed no further screening, rescreening after 10 years, low-intensity surveillance (10 yea…